Home/Filings/4/0000914190-18-000567
4//SEC Filing

Spandow Oliver J. 4

Accession 0000914190-18-000567

CIK 0001196298other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:27 PM ET

Size

6.4 KB

Accession

0000914190-18-000567

Insider Transaction Report

Form 4
Period: 2018-12-14
Transactions
  • Award

    Common Stock

    2018-12-14+18,03088,080 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.62Exp: 2028-08-10Common Stock (85,199 underlying)
    85,199
Footnotes (2)
  • [F1]On December 14, 2018, the Company granted 18,030 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Spandow in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]The option vests as to 28,400 shares on each of 8/10/19 and 8/10/20 and as to 28,399 shares on 8/10/21.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001749836

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:27 PM ET
Size
6.4 KB